From: Effects of an artificial pancreas on postoperative inflammation in patients with esophageal cancer
Ā | AP group (nā=ā27) | Control group (nā=ā69) | p-value |
---|---|---|---|
Pneumonia | Ā | Ā | 0.6942 |
āpresent āabsent | 6(22.2%) 21(77.8%) | 18(26.1%) 51(73.9%) | Ā |
Respiratory complications* | Ā | Ā | 0.3392 |
āpresent āabsent | 10(37.0%) 17(63.0%) | 33(47.8%) 36(52.2%) | Ā |
Anastomotic leakage | Ā | Ā | 0.8340 |
āpresent āabsent | 6(22.2%) 21(77.8%) | 14(20.3%) 55(79.7%) | Ā |
SSI | Ā | Ā | 0.3977 |
āpresent āabsent | 1(3.7%) 26(96.3%) | 6(8.7%) 63(91.3%) | Ā |